Developer docs
API playgroundTry for free, no card

Search company profiles

International Chemical Investors Group

Full company profile

uuid0008aa2

Namestring
International Chemical Investors Group
Legal namestring
ICI Holding SE
Company typeenum
Private
Founded yearint
2004
Descriptiontext

International Chemical Investors Group (ICIG) is a privately owned industrial holding company headquartered in Luxembourg with its principal corporate entity ICI Holding SE registered in Frankfurt, Germany. Founded in 2004, ICIG acquires non-core chemical businesses — typically carve-outs from large multinational corporates such as Rütgers, Clariant, Albemarle, INEOS, Evonik, Valtris, BASF, and Venator — and develops them as independently operated, niche-leading specialty chemical companies. Since inception, the group has acquired more than 30 businesses and currently operates six market-oriented platforms: WeylChem (fine chemicals, custom manufacturing, and advanced intermediates for pharmaceutical, agrochemical, and polymer customers); Catexel (care chemicals including bleach activators, hydrotropes, and optical brighteners for home and personal care); Benvic (thermoplastic compounds based on PVC, engineering polymers, and bio-polymers); Haltermann Carless (hydrocarbon specialties, performance fuels, and transformer oil services with sales reach in more than 90 countries); Stockhausen (superabsorbent polymers and acrylic acid, formed in 2024 from Evonik's superabsorbents business); and Enterprises (specialized businesses including activated carbon, fermentation, wood protection, viscose filament yarn, pigments, and industrial drying services). ICIG also operates ICIG Ventures, a venture capital arm investing in industrial biotechnology, chemistry, and advanced materials startups.

ICIG's underlying technology is rooted in specialized chemical manufacturing and custom synthesis. WeylChem operates eight manufacturing facilities across Europe and India with capabilities in bromination, chlorination, C-C coupling, diazo chemistry, Friedel-Crafts alkylation and acylation, Grignard reactions, halogen exchange, hydrogenation, sulfuric acid production, and glyoxal/glyoxylic acid derivatives. Catexel is the world market leader for bleach activators and catalysis and the largest hydrotropes producer in the United States, with additional capacity in low-temperature chemistry, oxidation, TAED, sodium paraffin sulfonate, and optical brighteners. Benvic produces bio-based and compostable thermoplastic compounds, mission-critical medical compounds, halogen-free flame retardant compounds, and recycled solutions across seven manufacturing sites plus one recycling center in Europe and the US. Stockhausen operates four manufacturing sites producing FAVOR-brand superabsorbent polymers and acrylic acid. Corden BioChem operates microbial fermentation and bioethanol facilities, including a restarted plant in Podari, Romania.

ICIG generates revenue through the manufacture and sale of specialty chemicals, fine chemicals, care chemicals, hydrocarbon specialties, superabsorbents, thermoplastic compounds, and other chemical products to global industrial customers in pharmaceutical, agrochemical, polymer, consumer products, water treatment, hygiene, textile, and wood protection sectors. The group operates on a sales-led, B2B direct-distribution model, with each platform maintaining dedicated direct-sales organizations and platform-specific websites, serving enterprise customers across Europe, the United States, and Asia. Group-level revenue exceeds €2.8 billion annually across approximately 5,950 employees and more than 45 manufacturing plants, with no public equity listing and ownership retained by founding management.

Short descriptiontext

International Chemical Investors Group is a privately owned Luxembourg-based industrial holding company that acquires and develops non-core specialty chemical businesses from large corporates, operating six platforms — WeylChem, Catexel, Benvic, Haltermann Carless, Stockhausen, and Enterprises — serving pharmaceutical, agrochemical, consumer, and industrial customers with over €2.8 billion in annual sales.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersLuxembourg, Luxembourg
HQ citystring
Luxembourg
HQ countrystring
Luxembourg
HQ regionstring
Europe
Markets served

Serves global market

Offices54 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty chemicals, fine chemicals manufacturing, custom chemical synthesis, thermoplastic compounds, superabsorbent polymers
Industry4 codes
1Electronic & High-Purity Specialty Chemicals
CodeIMAEABADPrimaryYes
2Medical & Food-Contact Specialty Compounds
CodeIMANABAKPrimaryNo
3Commodity Surfactants & Detergent Base Chemicals
CodeIMAEAAAIPrimaryNo
4Base Aromatics (BTX: Benzene, Toluene, Xylenes)
CodeIMAEADABPrimaryNo
NAICS code3 codes
  • Chemical Manufacturing325
  • Basic Chemical Manufacturing3251
  • Other Chemical Product and Preparation Manufacturing3259
SIC code2 codes
  • Industrial Organic Chemicals2860
  • Chemicals & Allied Products2800
Product category
Specialty Chemicals
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Chemicals Manufacturing and Sales
TypeOne Time License
Description

ICIG generates revenue through the manufacture and sale of specialty chemicals, fine chemicals, care chemicals, hydrocarbon specialties, superabsorbents, thermoplastic compounds, and other chemical products across its operating platforms.

ic-investors.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Operations, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1WeylChem
Description

Fine chemicals platform of ICIG providing custom manufacturing and advanced intermediates for pharmaceutical, agrochemical, and polymer industries.

ic-investors.com
+7 more records
Core offering1 text field

International Chemical Investors Group (ICIG) is a privately owned industrial holding company that acquires mid-sized chemical businesses from large corporations and develops them as independently operated specialty chemical manufacturers. The group operates six main platforms — WeylChem (Fine Chemicals), Catexel (Care Chemicals), Benvic (Compounds), Haltermann Carless (Hydrocarbons & Solvents), Stockhausen (Superabsorber), and Enterprises — producing custom-manufactured intermediates, performance chemicals, thermoplastic compounds, hydrocarbon specialties, superabsorbents, and other specialty products for pharmaceutical, agrochemical, polymer, consumer products, water treatment, and industrial customers.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

International Chemical Investors Group (ICIG) is a privately owned industrial holding company with sales exceeding €2.8 billion and approximately 5,950 employees worldwide. The company operates through six distinct platforms: WeylChem (Fine Chemicals) for custom manufacturing and advanced intermediates; Catexel (Care Chemicals) for specialty chemicals in home/personal care and cleaning; Benvic (Compounds) for thermoplastic compounds including PVC, engineering polymers, and bio-polymers; Haltermann Carless (Hydrocarbons & Solvents) for hydrocarbon specialties; Stockhausen (Superabsorber) for acrylic acid and superabsorbent polymers; and Enterprises for specialized chemical businesses including activated carbon, fermentation, wood protection, and industrial services. ICIG Ventures serves as the venture capital arm investing in industrial biotechnology, chemistry, and materials startups.

Scale indicator21 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-01
Description

Sachtleben Chemie International GmbH re-established on 1 February 2026 when ICIG acquired Barium Sulphate, Zinc Sulfide based Functional Additives and nano-fine Titanium Dioxide business from Venator Germany GmbH

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-16
Description

Catexel signed agreement to acquire BASF's optical brightening agent business from BASF's Care Chemicals division for laundry detergent formulations

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-08-12
Description

ICIG Ventures announced cooperation agreement with New Iridium to advance next-generation photocatalytic technologies in chemical manufacturing for low-carbon and clean chemistry

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-11-04
Description

ICIG and Vynova Group acquisition of European Advanced Organics business from Valtris Specialty Chemicals including production plants in Tessenderlo (Belgium) and Maastricht (Netherlands) plus benzyl chloride derivatives portfolio

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-09-01
Description

ICIG completed acquisition of Evonik Superabsorbents business including production facilities at five locations in Germany and United States with approximately 1,000 employees, forming Stockhausen platform

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-07-30
Description

ICIG signed agreement with Clariant to purchase decommissioned bioethanol plant in Podari, Romania to be operated by Corden BioChem biotechnology subsidiary

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-03-01
Description

ICIG acquired majority stake in Vasant Chemicals in March 2024, integrating into WeylChem Group to strengthen global expansion and enhance specialty chemicals market position

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

HCS Group acquisition formed basis for new Hydrocarbons & Solvents platform within ICIG, completed in Q3 2023

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

German specialty chemicals company with comparable end-market exposure in performance chemicals, advanced industrial intermediates and specialty additives across Europe, the US and Asia. Similar in scale (~€6-7B revenue) and in operating philosophy of running niche-leading specialty assets carved out or spun out of larger chemical groups.

TypeDirect peer
Description

Privately held German specialty chemicals group focused on additives, coatings, electrical insulation and pigments. Closely comparable to ICIG in being a family/founder-controlled private industrial holding that runs specialty chemical businesses with leading niche positions.

TypeBroad incumbent
Description

German specialty chemicals major (€15B+ revenue) from which ICIG has acquired multiple businesses (superabsorbents, Lulsdorf site). Overlaps with ICIG in specialty additives, superabsorbents and fine chemicals and serves as a key source of divestiture flow for ICIG.

TypeBroad incumbent
Description

Swiss specialty chemicals company focused on care chemicals, catalysts and natural resources. ICIG acquired Clariant's Custom Manufacturing business in 2007 and a Clariant bioethanol plant in 2024, with overlapping capabilities in care chemicals (vs. Catexel) and custom synthesis (vs. WeylChem).

TypeBroad incumbent
Description

French specialty materials group with €9-10B revenue across adhesives, advanced materials and coating solutions. Comparable to ICIG in European base, B2B specialty chemicals focus and downstream exposure to construction, automotive and consumer durables.

TypeBroad incumbent
Description

German specialty chemicals company with operations in silicones, polymers, biosolutions and polysilicon. Comparable to ICIG in being a European-headquartered, family-influenced specialty chemicals group with deep chemical engineering capabilities and global manufacturing.

TypeBroad incumbent
Description

Belgian chemicals group (split into Syensqo for specialty and Solvay for soda ash/chemicals). ICIG acquired Synkem from Solvay Pharma (2007) and INOVYN chlorovinyls (joint with INEOS, 2015) which became Vynova, making it both a counterparty and a key benchmark for specialty/soda ash valuations.

TypeBroad incumbent
Description

Privately held European chemicals conglomerate spanning petrochemicals, specialty chemicals and consumer products. Comparable to ICIG in private ownership, acquisition-driven growth and commodity-to-specialty portfolio, including joint INOVYN ownership that spun out Vynova to ICIG.

TypeBroad incumbent
Description

UK-listed specialty chemicals company focused on personal care, life sciences and performance technologies. Comparable to ICIG/Catexel in care chemicals, surfactants and consumer-adjacent specialty ingredients, and to WeylChem in supplying pharmaceutical and agrochemical customers.

TypeEmerging player
Description

US-listed specialty chemicals platform built via serial acquisitions of niche electronics, industrial and automotive chemical businesses. Operates with a similar 'buy-and-operate niche leaders' playbook to ICIG, albeit in different end-markets (electronics assembly, automotive).

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment10 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile8 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature23 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries10 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

International Chemical Investors Group

Specialty Chemicalsic-investors.com

International Chemical Investors Group is a privately owned Luxembourg-based industrial holding company that acquires and develops non-core specialty chemical businesses from large corporates, operating six platforms — WeylChem, Catexel, Benvic, Haltermann Carless, Stockhausen, and Enterprises — serving pharmaceutical, agrochemical, consumer, and industrial customers with over €2.8 billion in annual sales.

What International Chemical Investors Group does

International Chemical Investors Group (ICIG) is a privately owned industrial holding company headquartered in Luxembourg with its principal corporate entity ICI Holding SE registered in Frankfurt, Germany. Founded in 2004, ICIG acquires non-core chemical businesses — typically carve-outs from large multinational corporates such as Rütgers, Clariant, Albemarle, INEOS, Evonik, Valtris, BASF, and Venator — and develops them as independently operated, niche-leading specialty chemical companies. Since inception, the group has acquired more than 30 businesses and currently operates six market-oriented platforms: WeylChem (fine chemicals, custom manufacturing, and advanced intermediates for pharmaceutical, agrochemical, and polymer customers); Catexel (care chemicals including bleach activators, hydrotropes, and optical brighteners for home and personal care); Benvic (thermoplastic compounds based on PVC, engineering polymers, and bio-polymers); Haltermann Carless (hydrocarbon specialties, performance fuels, and transformer oil services with sales reach in more than 90 countries); Stockhausen (superabsorbent polymers and acrylic acid, formed in 2024 from Evonik's superabsorbents business); and Enterprises (specialized businesses including activated carbon, fermentation, wood protection, viscose filament yarn, pigments, and industrial drying services). ICIG also operates ICIG Ventures, a venture capital arm investing in industrial biotechnology, chemistry, and advanced materials startups.

ICIG's underlying technology is rooted in specialized chemical manufacturing and custom synthesis. WeylChem operates eight manufacturing facilities across Europe and India with capabilities in bromination, chlorination, C-C coupling, diazo chemistry, Friedel-Crafts alkylation and acylation, Grignard reactions, halogen exchange, hydrogenation, sulfuric acid production, and glyoxal/glyoxylic acid derivatives. Catexel is the world market leader for bleach activators and catalysis and the largest hydrotropes producer in the United States, with additional capacity in low-temperature chemistry, oxidation, TAED, sodium paraffin sulfonate, and optical brighteners. Benvic produces bio-based and compostable thermoplastic compounds, mission-critical medical compounds, halogen-free flame retardant compounds, and recycled solutions across seven manufacturing sites plus one recycling center in Europe and the US. Stockhausen operates four manufacturing sites producing FAVOR-brand superabsorbent polymers and acrylic acid. Corden BioChem operates microbial fermentation and bioethanol facilities, including a restarted plant in Podari, Romania.

ICIG generates revenue through the manufacture and sale of specialty chemicals, fine chemicals, care chemicals, hydrocarbon specialties, superabsorbents, thermoplastic compounds, and other chemical products to global industrial customers in pharmaceutical, agrochemical, polymer, consumer products, water treatment, hygiene, textile, and wood protection sectors. The group operates on a sales-led, B2B direct-distribution model, with each platform maintaining dedicated direct-sales organizations and platform-specific websites, serving enterprise customers across Europe, the United States, and Asia. Group-level revenue exceeds €2.8 billion annually across approximately 5,950 employees and more than 45 manufacturing plants, with no public equity listing and ownership retained by founding management.

International Chemical Investors Group firmographics

Firmographics
Name
International Chemical Investors Group
Legal name
ICI Holding SE
Website
https://ic-investors.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
International Chemical Investors Group is a privately owned Luxembourg-based industrial holding company that acquires and develops non-core specialty chemical businesses from large corporates, operating six platforms — WeylChem, Catexel, Benvic, Haltermann Carless, Stockhausen, and Enterprises — serving pharmaceutical, agrochemical, consumer, and industrial customers with over €2.8 billion in annual sales.
Ownership category
akta.pro rank

International Chemical Investors Group industry classification

Industry
Product category
Specialty Chemicals
NAICS
Chemical Manufacturing (325), Basic Chemical Manufacturing (3251), Other Chemical Product and Preparation Manufacturing (3259)
SIC
Industrial Organic Chemicals (2860), Chemicals & Allied Products (2800)
akta.pro primary industry
Electronic & High-Purity Specialty Chemicals (IMAEABAD)
akta.pro secondary industries
Medical & Food-Contact Specialty Compounds (IMANABAK), Commodity Surfactants & Detergent Base Chemicals (IMAEAAAI), Base Aromatics (BTX: Benzene, Toluene, Xylenes) (IMAEADAB)

Keywords

  • Specialty chemicals
  • Fine chemicals manufacturing
  • Custom chemical synthesis
  • Thermoplastic compounds
  • Superabsorbent polymers

Where International Chemical Investors Group is headquartered

Location

Headquarters

HQ city
Luxembourg
HQ country
Luxembourg
HQ region
Europe

Offices54 records

Markets served

International Chemical Investors Group business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Chemicals Manufacturing and Sales: ICIG generates revenue through the manufacture and sale of specialty chemicals, fine chemicals, care chemicals, hydrocarbon specialties, superabsorbents, thermoplastic compounds, and other chemical products across its operating platforms.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels4 records

International Chemical Investors Group product offering

Product offering

Core offering

International Chemical Investors Group (ICIG) is a privately owned industrial holding company that acquires mid-sized chemical businesses from large corporations and develops them as independently operated specialty chemical manufacturers. The group operates six main platforms — WeylChem (Fine Chemicals), Catexel (Care Chemicals), Benvic (Compounds), Haltermann Carless (Hydrocarbons & Solvents), Stockhausen (Superabsorber), and Enterprises — producing custom-manufactured intermediates, performance chemicals, thermoplastic compounds, hydrocarbon specialties, superabsorbents, and other specialty products for pharmaceutical, agrochemical, polymer, consumer products, water treatment, and industrial customers.

Product overview

International Chemical Investors Group (ICIG) is a privately owned industrial holding company with sales exceeding €2.8 billion and approximately 5,950 employees worldwide. The company operates through six distinct platforms: WeylChem (Fine Chemicals) for custom manufacturing and advanced intermediates; Catexel (Care Chemicals) for specialty chemicals in home/personal care and cleaning; Benvic (Compounds) for thermoplastic compounds including PVC, engineering polymers, and bio-polymers; Haltermann Carless (Hydrocarbons & Solvents) for hydrocarbon specialties; Stockhausen (Superabsorber) for acrylic acid and superabsorbent polymers; and Enterprises for specialized chemical businesses including activated carbon, fermentation, wood protection, and industrial services. ICIG Ventures serves as the venture capital arm investing in industrial biotechnology, chemistry, and materials startups.

Differentiator

Problem solved

Functional benefit

Brands

  • WeylChem: Fine chemicals platform of ICIG providing custom manufacturing and advanced intermediates for pharmaceutical, agrochemical, and polymer industries.
  • Catexel
  • Benvic
  • Haltermann Carless
  • Stockhausen
  • ICIG Ventures
  • Vynova
  • CordenPharma

Companies that use International Chemical Investors Group

Customer profile

Segments10 records

Ideal customer profiles8 records

International Chemical Investors Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature23 records

International Chemical Investors Group partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • Venator Germany GmbH (Barium Sulphate, Zinc Sulfide, TiO2)coreStrategic or Co-development Partner · 1 February 2026Sachtleben Chemie International GmbH re-established on 1 February 2026 when ICIG acquired Barium Sulphate, Zinc Sulfide based Functional Additives and nano-fine Titanium Dioxide business from Venator Germany GmbH
  • BASF Optical Brightener BusinesscoreStrategic or Co-development Partner · 16 December 2025Catexel signed agreement to acquire BASF's optical brightening agent business from BASF's Care Chemicals division for laundry detergent formulations
  • New IridiumcoreStrategic or Co-development Partner · 12 August 2025ICIG Ventures announced cooperation agreement with New Iridium to advance next-generation photocatalytic technologies in chemical manufacturing for low-carbon and clean chemistry
  • Valtris Advanced OrganicscoreStrategic or Co-development Partner · 4 November 2024ICIG and Vynova Group acquisition of European Advanced Organics business from Valtris Specialty Chemicals including production plants in Tessenderlo (Belgium) and Maastricht (Netherlands) plus benzyl chloride derivatives portfolio
  • Evonik Superabsorbents BusinesscoreStrategic or Co-development Partner · 1 September 2024ICIG completed acquisition of Evonik Superabsorbents business including production facilities at five locations in Germany and United States with approximately 1,000 employees, forming Stockhausen platform
  • Clariant Bioethanol Plant RomaniaminorStrategic or Co-development Partner · 30 July 2024ICIG signed agreement with Clariant to purchase decommissioned bioethanol plant in Podari, Romania to be operated by Corden BioChem biotechnology subsidiary
  • Vasant ChemicalscoreStrategic or Co-development Partner · 1 March 2024ICIG acquired majority stake in Vasant Chemicals in March 2024, integrating into WeylChem Group to strengthen global expansion and enhance specialty chemicals market position
  • HCS GroupcoreStrategic or Co-development Partner · 1 January 2023HCS Group acquisition formed basis for new Hydrocarbons & Solvents platform within ICIG, completed in Q3 2023

Scale indicators21 records

Recent moves6 records

Expansion highlights6 records

International Chemical Investors Group competitors and assessment

Company assessment

Direct peers

  • Lanxess AG: German specialty chemicals company with comparable end-market exposure in performance chemicals, advanced industrial intermediates and specialty additives across Europe, the US and Asia. Similar in scale (~€6-7B revenue) and in operating philosophy of running niche-leading specialty assets carved out or spun out of larger chemical groups.
  • Altana AG: Privately held German specialty chemicals group focused on additives, coatings, electrical insulation and pigments. Closely comparable to ICIG in being a family/founder-controlled private industrial holding that runs specialty chemical businesses with leading niche positions.

Broad incumbents

  • Evonik Industries AG: German specialty chemicals major (€15B+ revenue) from which ICIG has acquired multiple businesses (superabsorbents, Lulsdorf site). Overlaps with ICIG in specialty additives, superabsorbents and fine chemicals and serves as a key source of divestiture flow for ICIG.
  • Clariant AG: Swiss specialty chemicals company focused on care chemicals, catalysts and natural resources. ICIG acquired Clariant's Custom Manufacturing business in 2007 and a Clariant bioethanol plant in 2024, with overlapping capabilities in care chemicals (vs. Catexel) and custom synthesis (vs. WeylChem).
  • Arkema SA: French specialty materials group with €9-10B revenue across adhesives, advanced materials and coating solutions. Comparable to ICIG in European base, B2B specialty chemicals focus and downstream exposure to construction, automotive and consumer durables.
  • Wacker Chemie AG: German specialty chemicals company with operations in silicones, polymers, biosolutions and polysilicon. Comparable to ICIG in being a European-headquartered, family-influenced specialty chemicals group with deep chemical engineering capabilities and global manufacturing.
  • Solvay SA: Belgian chemicals group (split into Syensqo for specialty and Solvay for soda ash/chemicals). ICIG acquired Synkem from Solvay Pharma (2007) and INOVYN chlorovinyls (joint with INEOS, 2015) which became Vynova, making it both a counterparty and a key benchmark for specialty/soda ash valuations.
  • INEOS Group: Privately held European chemicals conglomerate spanning petrochemicals, specialty chemicals and consumer products. Comparable to ICIG in private ownership, acquisition-driven growth and commodity-to-specialty portfolio, including joint INOVYN ownership that spun out Vynova to ICIG.
  • Croda International plc: UK-listed specialty chemicals company focused on personal care, life sciences and performance technologies. Comparable to ICIG/Catexel in care chemicals, surfactants and consumer-adjacent specialty ingredients, and to WeylChem in supplying pharmaceutical and agrochemical customers.

Emerging players

  • Element Solutions Inc. US-listed specialty chemicals platform built via serial acquisitions of niche electronics, industrial and automotive chemical businesses. Operates with a similar 'buy-and-operate niche leaders' playbook to ICIG, albeit in different end-markets (electronics assembly, automotive).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

International Chemical Investors Group social profiles

Digital presence

International Chemical Investors Group compliance and trust

Trust signal

Compliance3 records

International Chemical Investors Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

International Chemical Investors Group leadership team

Management profile

Number of profiles

Profiles2 records

International Chemical Investors Group subsidiaries and ownership

Company hierarchy

Subsidiaries10 records

International Chemical Investors Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

International Chemical Investors Group M&A and investment

M&A and investment

M&A4 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about International Chemical Investors Group

What does International Chemical Investors Group do?

International Chemical Investors Group (ICIG) is a privately owned industrial holding company that acquires mid-sized chemical businesses from large corporations and develops them as independently operated specialty chemical manufacturers. The group operates six main platforms — WeylChem (Fine Chemicals), Catexel (Care Chemicals), Benvic (Compounds), Haltermann Carless (Hydrocarbons & Solvents), Stockhausen (Superabsorber), and Enterprises — producing custom-manufactured intermediates, performance chemicals, thermoplastic compounds, hydrocarbon specialties, superabsorbents, and other specialty products for pharmaceutical, agrochemical, polymer, consumer products, water treatment, and industrial customers.

Is International Chemical Investors Group a public or private company?

International Chemical Investors Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was International Chemical Investors Group founded?

International Chemical Investors Group was founded in 2004. It employs 5,001 to 10,000 people.

Where is International Chemical Investors Group based?

International Chemical Investors Group is headquartered in Luxembourg, Luxembourg, in the Europe region.

How does International Chemical Investors Group make money?

One revenue line is on record: chemicals Manufacturing and Sales.

Who are International Chemical Investors Group's main competitors?

Direct peers on record are Lanxess AG and Altana AG. Broad incumbents are Evonik Industries AG, Clariant AG, Arkema SA, Wacker Chemie AG, Solvay SA, INEOS Group and Croda International plc. Element Solutions Inc. is listed as an emerging player.

Does International Chemical Investors Group have an API?

No public API is recorded for International Chemical Investors Group.

What industry is International Chemical Investors Group in?

International Chemical Investors Group's product category is Specialty Chemicals. Its primary akta.pro industry code is IMAEABAD, Electronic & High-Purity Specialty Chemicals, with a secondary code of IMANABAK, Medical & Food-Contact Specialty Compounds. Its NAICS code is 325 and its SIC code is 2860.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TalkMarketsGLOBAL GLYOXAL MARKET SIZE, SHARE & FORECAST 2031 (CAGR 4.77%)TechSci Research projects the global glyoxal market to grow from USD 414.02 million in 2025 to USD 547.57 million by 2031, registering a CAGR of 4.77%, with Asia Pacific as the dominant regional market driven by textile and paper production in China and India. Key growth drivers include regulatory shifts away from formaldehyde toward glyoxal as a safer crosslinking agent, rising demand for crease-resistant textiles, and increasing adoption of fiber-based packaging as a plastic alternative. Recent market activity includes International Chemical Investors Group's majority stake acquisition of Vasant Chemicals in March 2024, BASF reporting approximately €11 billion in sales from products launched within five years, and Hubei Hongyuan Pharmaceutical announcing a share-repurchase program.openPR.comAn Overview of Segmentation, Market Dynamics, and Competitive Landscape in the Production Chemicals MarketThe production chemicals market is projected to reach $9.59 billion by 2030, growing at a compound annual growth rate of 6.1%, driven by aging oilfield infrastructure, enhanced oil recovery projects, stricter environmental regulations, and increased offshore exploration activities. International Chemical Investors Group (ICIG) acquired Vasant Chemicals in March 2024, a move that strengthens WeylChem's global expansion while enhancing Vasant Chemicals' position in the specialty chemicals market. Swiss industrial engineering firm Sulzer Ltd. launched SULAC technology in December 2023, enabling polylactic acid producers to add lactic acid to lactide production capabilities.Ic-InvestorsInternational Chemical Investors Group (ICIG) announces acquisition of a majority stake in Vasant ChemicalsInternational Chemical Investors Group (ICIG) has closed the acquisition of a majority stake in Vasant Chemicals, an Indian specialty chemicals manufacturer, to integrate it into its WeylChem platform. This transaction aims to expand WeylChem's presence in the global specialty chemicals market and provide access to the fast-growing Indian market through Vasant Chemical's manufacturing facilities and expertise.Ic-InvestorsInternational Chemical Investors (ICIG) to acquire Nisso’s MSSA to further expand its chlor-alkali operationsInternational Chemical Investors (ICIG) has made a firm and binding offer to acquire sodium metal specialist Métaux Spéciaux (MSSA) from Nippon Soda, with exclusive negotiations underway. MSSA, based in France with facilities in Pomblière and La Rochelle and a terminal in Pasadena, Texas, is the largest non-Chinese producer of purified sodium metal. The deal requires employee consultation and approval from German, Spanish and Portuguese competition authorities.